SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 33.34-2.1%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (17276)2/23/2007 10:49:17 AM
From: bob zagorin   of 17367
 
and a little more from Q

:...-- XOMA entered into a five-year, $35.0 million term loan facility
with Goldman Sachs Specialty Lending Holdings, Inc. and borrowed
the full amount thereunder. The loan will bear interest at an
annual rate equal to six-month LIBOR plus 5.25% and is secured by
all rights to receive payments due XOMA relating to RAPTIVA(r),
LUCENTIS(tm) and CIMZIA(tm). Payments received by XOMA in respect
of these payment rights will be used to make semi-annual interest
payments under the facility, and amounts in excess of interest
requirements may be used to pay down principal at the discretion
of the lender. Proceeds will be used for general corporate
purposes. This financing is not dilutive to shareholders, and
XOMA remains the owner of these royalty streams, subject to the
pledge...."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News